Table 2. Mean value during the activation period (m ₁): MC.

(scale: 10−5 µM)
Subs.	Ch.1	Ch.2	Ch.3	Ch.4	Ch.5	Ch.6	Ch.7	Ch.8	Ch.9	Ch.10
1	16.11	−3.93	−0.60	6.07	4.21	8.22	3.82	4.03	4.30	−2.00
2	−5.23	7.13	−1.94	−5.22	4.81	6.51	5.10	5.18	7.09	4.33
3	0.21	3.24	−3.48	1.14	−2.31	1.45	0.00	−0.01	8.73	6.23
4	4.77	2.12	3.39	−0.43	−5.02	7.56	−0.22	2.11	−10.94	−1.83
5	1.67	−4.33	3.36	2.58	−0.14	−0.85	0.20	4.18	3.30	5.50
6	5.87	−5.42	1.35	3.68	−1.54	−8.92	6.67	−4.54	8.32	6.78
7	−4.02	−3.08	1.37	5.62	6.72	−2.35	4.66	−1.82	−1.65	5.81
8	−1.63	2.04	3.81	0.73	1.04	−0.63	5.01	1.83	10.77	−1.72
9	−2.92	−2.61	−0.25	−4.20	6.91	2.61	2.14	2.13	3.67	5.15
10	−6.08	−11.16	1.90	4.18	3.56	18.37	11.24	4.80	0.51	−3.51
11	4.99	3.18	2.72	1.18	5.29	−0.07	7.04	1.30	1.74	4.41
12	2.47	1.73	−4.20	−7.16	−0.39	−9.93	1.68	3.08	9.23	−1.43
13	0.82	0.03	−2.79	3.43	−2.70	−9.52	6.70	2.80	2.15	0.11
14	1.59	0.00	1.49	1.22	−2.37	2.24	5.05	−6.17	0.00	2.03
15	4.29	2.17	0.00	−4.52	4.68	2.19	3.48	−5.53	7.09	3.42
16	7.41	4.82	7.23	−0.62	−1.04	0.00	−3.34	0.00	12.40	16.33
17	3.05	4.77	−3.84	0.00	4.08	4.27	0.00	3.16	4.05	5.25
18	2.85	−2.91	−1.34	−1.16	1.39	−3.78	5.67	−5.39	−3.08	−6.10
19	−0.05	0.47	−2.52	0.21	6.41	4.31	2.25	0.00	−1.74	1.79
Avg*	1.90	-0.09	0.30	0.35	1.77	1.14	3.53	0.59	3.47	2.66
SD**	5.10	4.39	3.07	3.64	3.69	6.77	3.41	3.65	5.65	5.02

* The Avg row indicates the average value over 19 subjects.

** SD denotes standard deviation.